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highly effective and safe primary treatment modality. Initial thrombosis rates exceeded
90% and no serious complications were observed in this series despite a high rate of
concomitant antiplatelet and antithrombotic therapy.
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Background: The preclose technique with the 6 F Proglide for complete percutaneous
endovascular aortic repair have not been sufficiently evaluated. We investigated the
efficacy and safety of the preclose technique in a sufficient and large cases.
Methods: The medical records of 367 patients with 599 preclose techniques for various
aortic repairs were reviewed. Procedural success was defined as hemostasis achieved by
the preclose technique, without the need for surgical or endovascular procedures. Access
related major adverse event (ARMAE)s were considered as those event, such as infection,
bleeding, new onset ischemia of the lower leg, hematoma, pseudoaneurysm, arteriovenous
fistula, embolization, laceration, femoral artery thrombosis, nerve injury, or death by
access site injury.
Results: Procedural success was achieved in 359 of 367 patients (97.8%) and 591 of 599
left or right femoral sites (98.7%). All cases of procedural failure were treated by
immediate surgical repair of femoral arteries. The preclose technique was more successful
in the smaller sheath. ARMAEs developed in 25 of 367 patients (6.8%) and 26 of 599
sites (4.3%). Access site hematoma was the most frequent adverse events (16 of 367
patients (4.4%) and 17 of 599 sites (2.8%)), followed by puncture site pseudoaneurysm (7
of 367 patients (1.9%) and 7 of 599 sites (1.2%)). Bleeding after arterial closure occurred
in 6 of 367 patients (1.6%) and 6 of 599 sites (1.0%). In 2 of 367 patients (0.5%), there
was an infection at the puncture site. There were two cases of distal embolization, one case
of acute femoral thrombosis, and one case of a vascular laceration at the puncture site.
There were no access site related nerve injury, arteriovenous fistula or death complicated
by access site.
Conclusions: The preclose technique can be used to achieve hemostasis for stent graft
procedure successfully, with a high rate of procedural success and an acceptable rate of
adverse event, the most common being puncture site hematoma formation.
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Background: Transradial approach (TRA) in percutaneous coronary intervention (PCI)
has increased over the past few years. Its use has been shown to decrease mortality
compared with the transfemoral approach (TFA) in patients with acute coronary
syndrome (ACS). Comparative studies have systematically excluded patients with
cardiogenic shock (CS).
Methods: We carried out a prospective, observational registry study of consecutive
patients undergoing emergent revascularization between February 2007 and January
2012. An analysis of the clinical evolution of patients with CS during hospitalization was
performed according to the approach used in the PCI.
Results: Of 1,400 emergency procedures, 122 had CS, 80 underwent PCI by TRA
(65.6%) and 42 by TFA (34.3%). The main reason for choosing TFA was the absence of
radial pulse (54.9%). Mortality (64.3% vs. 32.5%, p0.001), serious access site
complications (11.9% vs. 2.5%, p0.03) and MACE (combination of death, infarction,
stroke, serious bleeding, and postanoxemic encephalopathy) (73.8% vs. 43.8%, p0.001)
were greater in TFA patients. In the multivariate analysis, TRA was a predictor of
mortality (OR 0.39[0.15-0.97]); other predictive factors were age75 (3.47[1.35-8.92]),
previous treatment with diuretics (3.67[1.21-11.12]) and the success of the procedure
(0.08[0.02-0.24]).
Conclusions: In centers with experience, TRA approach for PCI is possible and safe in
patients with CS in up to two thirds of the patients. The main cause that prevented the use
of TRA was the absence of radial pulse. In the multivariate analysis, TRA was associated
with a lower risk of mortality.
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Background: Ballooon aortic valvulplasty can be useful for palliation of symptoms in
pts not eligible for surgical or transcatheter aortic vaalve replacement, or a a bridge to
AVR. Occassionally transfemoral access is impossible or challenging, due to vascular
disease or morbid obesity. We present our experience with trasnradial access for balloon
aortic valvulplasty in pts not candidates for transfemoral approach.
Methods: 5 pts presented with critical aortic stenosis without femoral access. Transradial
access was successfully obtained in all pts. In 1 pt a vascular loop prompted a change from
the right to the left radial approach - the others were done via right radial access. Internal
jugular venous access was used for PA catheter and pacing. After crossing the aortic valve
using 6Fr amplatz 1 catheter with straight wire, and changing out for a dual lumen pigtail.
Over an exchange length wire, the 6 Fr sheath was excheanged for an 8 Fr, and a 22 mm
Tyshack balloon was advanced across the aortic valve and dilated during rapid pacing.
Due to inadequate hemodynamics, in 1 case the 8 Fr sheath was exchanged for a 9 Fr, and
a 25 mm Tyshack balloon used.
Results: In 4 of 5 pts aortic valvuloplasty was attempted and successfully performed. In
1 pt with morbid orbesity vigourous diuresis was instead successful in treating his CHF
and one year later he underwent successful surgical AVR. 1 of the pts with successful
balloon valvuplasty had occlusive lower extremity arterial disease and need for warfarin
for a mechanical mitral valve, the others had morbid obesity (mean weight 168 kg). All
pts had hemodynamic improvement, mean AV gradient decreased from 47 to 36 (23%),
and AVA increased from 0.85 to 1.1 (29% increase). The pt with 9 Fr sheath had small
amount of tissue removed with removal of the 9 Fr sheath, but no clinical complications
in any pt.
Conclusions: Radial artery access is a feasible option for the performance of balloon
aortic valvuloplasty in patients with poor femoral artery access.
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Background: Vascular Hemostasis Devices (VHD) are regulated by FDA as high-risk
Class III medical devices requiring Pre-Market Approval (PMA). First approved in 1995,
these devices have evolved and been broadly adopted for hemostasis use, with current use
estimates up to 50% of all coronary procedures. FDA databases were searched to provide
a regulatory summary and device profile overview.
Methods: The PMA, Adverse Event, Recall, Registration and Inspection databases were
searched using the device product code and years 2007 through 2011. Statistical testing
used t-test and X2, as appropriate for proportions or means, with significance level of 0.05.
Results: The FDA registration and listing database identified 8 different manufacturers
and 11 different devices. FDA approval of the 11 devices occurred from 1995 through
2011. 10 of the 11 listed devices are made in the US by US manufacturers. Two
manufacturers represented 95% of the VHDs reported in adverse events. The number of
annual adverse events reports increased 300% from 1,402 in 2007 to 4,243 in 2011, with
a five year total of 14,120 reports received. Geographically, 72% of the adverse events
occurred in the US and 27% in 53 other countries. Females were disproportionately
represented (p 0.001, 44% vs. 34% expected). Patient age ranged from 4 to 98 years,
with women found to be older than men (65.8 vs. 64.7, p0.01). A total of 164 reports
for death as the patient outcome were received. For women, deaths were present in 3.38%
of the reports compared to 1.28% for men (p0.001, odds ratio 2.7 [CI 1.908, 3.802]).
During the timeframe there was one US recall for a compromised sterility issue and one
foreign recall for increased failure rates. US Manufacturer and contractor inspections
included four cases of FDA citations requiring actions.
Conclusions: Reasons women experience higher risks are not known but appear to
persist despite product experience and design changes. More research on gender
differences and device design is recommended. Increased overall numbers of VHD
adverse event reports to FDA likely parallels temporal increases in use. Limitations relate
to missing data for patient age and gender, and known underreporting of adverse events.
TCT-408
Sheathless Guide Catheters in complex Transradial PCI. A Single Center
Experience
Raul Valdesuso1, Francisco Lacunza1, Juan Gimeno1, Juan Garcia de Lara1,
Jose Hurtado1, Eduardo Pinar1, Mariano Valdes1
1Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
Background: The Sheathless Guiding Catheter (SGC) (Sheathless Eaucath, Asahi Intecc
Co, Japan) has Hydrophilic coatings that enhances catheter tractability through tortuous
vessels and allow dealing with radial spasm and performing Percutaneous Coronary
Intervention (PCI) by radial approach in complex cases. We reported our experience in 91
patients (pts) with complex transradial approach in whom SGC was used to avoid femoral
cross over to complete the procedure.
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Methods: Of 1918 PCI (1623 pts, aged 66  4 years old; 65% males) performed in our
catheterization laboratory from January the 1st 2011 to January the 31st 2012, the 70%
(1342) were performed via radial and 576 (30%) via femoral (187 cross over from radial,
324 due to operator criteria 65 for no appropriate Sheathless shape available) and 156 PCI
(142 pts) initially scheduled via femoral were rescue to radial using SGC. Reasons for
SGC use were: moderate to severe radial spasm in 48, tortuosity and/or subclavian
elongation in 36, proximal radial take-off in 12, insufficient backup or difficulties to
coronary engage in 23 and 37 by expected mismatch between radial artery and catheter
needed for PCI.
Results: A total of 164 SGC were employed (98 (60%) of 6.5 Fr), being Super Power
Backup (68%) the most common used followed by Amplatz left (21%). Successful rate
was 100%. 105 left and 51 right coronary were engaged with SGC. There were 5 left main
and 2 right coronary ostium (4,5%) iatrogenic dissections (all resolved with stent
implantation). In 13 (8.3 %) cases there was an insufficient backup due to backward slip
of the catheter at radial insertion point in the wrist that led to the need of active fixation
of the catheter at that point.
Conclusions: The larger inner diameter, hydrophilic coated and tractability of SGC
allows performing complex transradial procedure with a high successful rate and low
cross over rate. The risk of coronary ostiums dissection with SGC is not neegligible and
manufacturers should consider diminishing catheter tip’ stiffness. In complex procedures
(chronic occlusions, rotablator, etc) active fixation at the wrist should be considered to
avoid the backward slip of the catheter at the insertion point in the wrist.
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Background: The transradial approach (TRA) is widely being adopted as the preferred
method of access for coronary angiography. Previous studies have demonstrated that
access with the left radial approach (LRA) may have some advantages over the right radial
approach (RRA) such as decreased tortuosity and better catheter support. Few studies
have demonstrated a significant difference in the amount of fluoroscopy time (FT) and
environmental radiation exposure, but little data exist showing direct radiation exposure
to the operator when comparing these two approaches. The aim of this study is to
determine weather there is a significant difference in direct radiation exposure to the
operator when using a LRA versus a RRA.
Methods: A total of 60 consecutive patients were randomized to a LRA or RRA. Patients
with arteriovenous fistulas, prior coronary bypass surgery, or ST-elevation myocardial
infarcts were excluded. Radiation dosimeter badges (RDB) were strategically placed on
the head, external thyroid and internal sternum for each operator. Individual variables,
including FT, scenes, calculated radiation dose, Head RDB, External Thyroid RDB and
Internal Sternum RDB, were independently compared between LRA and RRA using a
two-sampled t-test.
Results: There was no significant difference in FT, scenes and calculated radiation dose
between LRA and RRA. However, a comparison of the RDB reveals a significant
difference in direct radiation exposure to the operators’ external thyroid RDB (p0.015)
and a trend towards significance in the head RDB (p0.070). There was no significant
difference in the internal sternum RDB measurements. (Table 1)
Table 1
LRA (n31) RRA (n29) p-value
FT (min) 13.18.9 11.58.2 0.483
Scenes 15.19 16.210 0.659
Calculated Radiation Dose (MGy) 1634921 18531545 0.512
Head RDB (mRems) 12.59.3 17.712.6 0.070
External Thyroid (mRems) 19.115.0 33.026.9 0.015
Internal Sternum (mRems) 3.04.5 4.05.3 0.462
Conclusions: There is a statistically significant increased risk of operator radiation
exposure seen in the external thyroid RDB, and a trend towards significance in the head
RDB, during a right radial approach.
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Arteriotomy Location Guided by Fluoroscopy Plus Real-time Ultrasound: In
Defense of the Femoral Approach
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Background: Vascular complications are increased by puncture above or below the
common femoral artery (CFA). The FAUST study showed that real-time ultrasound
guidance (USG) modestly increased accuracy over fluoroscopic guidance (86.4% vs
83.3% CFA punctures) and decreased vascular complications. We hypothesized that USG
accuracy could be improved.
Methods: 416 consecutive femoral sheath arteriograms were analyzed by a blinded
reviewer. Procedures were performed with USG alone or with fluoroscopic femoral
landmarks 	 USG (Xray	USG) by a single operator with USG experience. A
micropuncture system and ultrasound probe needle guide were used. We recorded the site
of arteriotomy in the femoral artery and also relative to the femoral head (FH), and the
relation of the femoral bifurcation (FBi) to the FH.
Results: The puncture was in the CFA in 97.3% (Xray	USG; n256) and 94.9% (USG;
n158; difference NS). The FBi was above the inferior border of the FH in 47.6% of
studies, and above the middle of the FH in 4.1%.
Conclusions: Despite many high bifurcations, Xray	USG guidance permitted CFA
puncture in 97.3% of catheterizations. The radial approach, pharmacologic improvements
and other strategies have focused attention on the importance of reducing bleeding and
vascular complications. Our series suggests that the Xray	USG technique may improve
outcomes when the femoral approach is needed, as for large catheter interventions.
TCT-411
Use of Sheathless Guide Catheter with Transradial Percutaneous Coronary
Intervention: Single Center Experience with 7853 Procedures
Mitsuru Kahata1, Norio Tada2, Taku Honda3, Kazunori Horie3,
Kaname Takizawa3, Tatsushi Otomo3, Naoto Inoue4, Taiichirou Meguro3
1Sendai Kousei Hospital, Sendai, Japan, Sendai, Japan, 2Sendai Kosei Hospital,
miyagi, Japan, 3Sendai Kosei Hospital, Sendai City, Miyagi Pref, 4Sendai Kousei
Hospital, Sendai, Japan
Background: Sheathless guide catheter is a hydrophilic catheter without use of an
introducer sheath so that it decreases stress to radial artery. Although transradial
percutaneous coronary intervention (TRI) using a sheathless guide catheter (Sheathless
TRI) associates potential limitations such as its procedural complexity or coronary ostial
dissection due to its tip stiffness, any large number studies have not shown the data yet.
Methods: Our institution has utilized transradial approach as an initial system for more
than ten years. Since we started to use sheathless TRI in 2004, with experiences and
improvement of devices sheathless TRI is currently utilized in most TRIs including
emergent cases, even in bifurcation or rotational atherectomy by using 7.5 Fr sheathless
TRI. We retrospectively investigated the feasibility and safety of sheathless TRI,
undertaken at our institution from January 2004 to December 2011.
Results: A total of 10293 PCIs was performed in this study period by 43 operators
including beginners to specialists. TRI was performed in 8868 cases, consisting of 7853
cases (88.5%) of sheathless TRI and 1015 cases (11.5%) of TRI using a conventional
sheath. In any cases other than chronic total occlusion procedural success, defined as
successful revascularization without conversion to other guide catheter systems, was
achieved in 98.9% of sheathless TRI and 98.0% of TRI using conventional sheath
(p0.018). Conversion from sheathless TRI to other system was occurred in 37 cases
(0.47%) including 35 cases from sheathless TRI to TRI using conventional sheath and 2
cases from it to transfemoral approach. Coronary ostium dissection was occurred in 20
cases (0.23%) in all TRIs including 16 cases (0.20%) by sheathless TRI and 4 cases
(0.39%) by TRI using conventional sheath (p0.28), which were all bailed out by stent
deployment resulting in procedural success. Critical arm ischemia requiring amputation or
resulting in persistent paralysis was not seen in any cases.
Conclusions: Use of sheathless guide catheter via transradial artery is a feasible approach
as an initial system for any interventionalists in any situations as long as transradial
approach is permitted.
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Diltiazem, verapamil or dinitrate isosorbid for prevention of radial artery
spasm in percutaneous coronary intervention
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1Cochin Hospital, Paris, France, 2Montreuil Hospital, Montreuil, France, 3VAL-
DE-GRACE HOSPITAL, PARIS, France
Background: Radial artery spasm (RAS) remains the major limitation of transradial
approach for percutaneous coronary interventions (PCI). We have previously demon-
strated efficacy of verapamil to reduce RAS but recently, supply problems have occurred
and many cathlab have changed verapamil to another calcium channel blocker, diltiazem.
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